Further, there is strong evidence to support the role of IL-17 in the protection of epithelial barrier function in the gut mucosa and airways; as such, systemic inhibition of IL-17 presents potential risk of candida infection and is associated with infection and disease worsening in these tissues (70–73). This evidence concerns the gene IL17A and candidiasis.